Download PDF

Other users also viewed these articles

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij;
10.1016/j.aohep.2024.101753
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: